BREVICON 0.5/35 TABLETS (21-DAY PACK)
PFIZER CANADA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BREVICON 0.5/35 TABLETS (21-DAY PACK) in Canada?
Yes. BREVICON 0.5/35 TABLETS (21-DAY PACK) 0.035MG 0.5MG has an active shortage reported to Health Canada (last updated May 19, 2026).
Why is BREVICON 0.5/35 TABLETS (21-DAY PACK) not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will BREVICON 0.5/35 TABLETS (21-DAY PACK) be available again?
The manufacturer's estimated resolution date is March 19, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-03-19
~6 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02187086
Strength
0.035MG 0.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ETHINYL ESTRADIOL NORETHINDRONE
Tier
Unrated
Last Updated
2026-05-19
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347